Status:
COMPLETED
Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy
Lead Sponsor:
Maggiore Bellaria Hospital, Bologna
Conditions:
Lung Cancer
Sarcoidosis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether rapid on-site cytopathologic evaluation (ROSE) can increase the diagnostic yield of transbronchial needle aspiration (TBNA) in the diagnosis of hilar ...
Eligibility Criteria
Inclusion
- 18 years old and older
- Hilar and/or mediastinal lymphadenopathy (\> 1 cm on the short axis, as assessed by contrast-enhanced CT scan (computed tomography))
Exclusion
- Uncontrolled coagulopathy
- Refusal to sign informed consent
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
End Date :
February 1 2010
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT00915330
Start Date
May 1 2009
End Date
February 1 2010
Last Update
February 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maggiore Hospital
Bologna, Italy, 40133